FastWave Medical

FastWave Medical is a clinical-stage medical device company based in Minneapolis, Minnesota. Founded in February 2021, the company specializes in developing advanced intravascular lithotripsy (IVL) systems aimed at treating calcific artery disease, including complex coronary artery disease and peripheral artery disease. FastWave focuses on creating efficient and cost-effective IVL catheters that deliver durable sonic energy to fracture calcified plaques, enhancing blood flow and vessel expansion. The flagship product, the Sola™ system, is designed for superior deliverability and efficacy in treating calcified coronary lesions. It features a low-profile actuating emitter and 360-degree sonic pressure output for effective calcium fracturing. FastWave is preparing for a coronary Investigational Device Exemption trial set to begin in early 2026. The company has raised over $40 million in funding and employs fewer than 25 people, with a reported revenue of approximately $6 million. FastWave Medical serves interventional cardiologists and vascular surgeons, providing innovative solutions for complex calcific lesions.

• Employees 27
• Founded 2021
• Total Funding $19000000